Insulin-contaminated IV bags

Insulin-contaminated IV bags transformed unexplained collapses at Saint Barnabas Medical Center into evidence of deliberate poisoning. A bag that appeared to contain only saline and heparin instead contained insulin; later testing connected the same kind of contamination to patients whose blood sugar repeatedly crashed while they were receiving heparin. The bags were both a means of harm and a material record of it: their contents, punctures, and movement through hospital storage gave investigators a way to challenge the appearance of ordinary medical mishap.

Discovery and physical evidence

On February 11, 1991, pharmacy nurse Pam Allen brought a suspicious IV bag to risk manager Karen Seiden. Its port looked used, yet the bag was filled nearly to the point of leaking. Seiden also thought it looked wrong, so she contacted Thomas Arnold, the assistant director of security and a former police officer. The bag went to the pathology lab. Although it was supposed to contain saline and heparin, testing found insulin as well.

A second bag made the first discovery harder to dismiss as an isolated anomaly. After Fred Belf’s nurses noticed that his condition improved when his heparin drip was disconnected, they removed the bag, sealed it in sterile plastic, and sent it for testing. It too tested positive for insulin. Microscopic examination of its exterior found tiny needle punctures, including three along the bag’s edges. Needles might accidentally puncture a saline bag where it connects to a stopcock, but punctures around the perimeter did not fit that ordinary explanation. To the investigators, the pattern suggested repeated, intentional tampering rather than a single handling error.

What the bags did to patients

On Valentine’s Day, three days after the first bag was tested, Anna Byers was receiving heparin when she became sweaty, confused, nauseous, and weak. Her insulin level was extraordinarily high. Orange juice did not reverse her decline, and she needed intravenous dextrose, sugar delivered directly into her bloodstream. Even that could not keep pace with the insulin. When her heparin drip was stopped before a planned procedure, her symptoms eased. After she returned to her room and the drip was started again, the crisis returned; she repeatedly stabilized and crashed until her blood sugar could no longer be measured. She was taken urgently to intensive care, but within twenty minutes of being off the drip she felt better.

Belf’s experience supplied another comparison. His heparin began at seven in the morning; by noon he was vomiting and unable to keep down orange juice. Doctors gave him dextrose intravenously alongside the heparin, and the two treatments continued through the day and night without resolving the crisis. By the following evening, staff had connected his symptoms to the heparin bag. Once it was disconnected, he quickly began to improve. In both cases, the patients’ deterioration tracked the infusion, and relief followed its removal. The bags made that repeated clinical sequence tangible.

Testing and chart review widened the concern beyond these two patients. Across intensive care, critical care, and cardiac units, patients had suffered unexplained blood-sugar crashes for months; the incidents were scattered across units and shifts, and some emergencies overlapped. Laboratory work found exceptionally high insulin levels, much of it foreign insulin rather than insulin produced by the patients’ bodies. Yet investigators found no doctor’s order for insulin and no nursing notation that it had been administered. The missing documentation left open two troubling possibilities: an undocumented medication error, or the administration of a drug that had never been prescribed.

From a contaminated bag to a suspect

The bags could establish that insulin was present where it should not have been, but they could not by themselves identify who had tampered with them. Arnold and Joe Barry, Saint Barnabas’s security chief and a former state police major, compared nursing schedules with the times of patient emergencies. Only three nurses had worked every code they examined; Charles Cullen drew particular attention. Arnold observed that Cullen seemed unusually unconcerned during interviews and repeatedly made himself difficult to schedule. When Arnold and Barry eventually brought him into a conference room, Cullen refused to answer questions.

The evidence still fell short of a conclusive case. A prosecutor who reviewed the investigation did not believe the available material was enough for him to act and advised that the hospital handle the matter internally. Arnold and Barry therefore tried to catch whoever was tampering with the bags: they installed stop-motion cameras in the medication storage room, interviewed staff and families, and introduced a more restrictive insulin sign-out procedure. When two more patients at Saint Barnabas suffered unexplained hypoglycemia in October and were found connected to insulin-tainted bags, suspicion remained, but investigators still lacked proof they could use to establish who had done it. Then Cullen stopped working there, and the insulin spikes stopped as well.

Cullen’s own account, as presented in the book, underscores the bags’ role as evidence. He believed investigators knew what he had done, including that he had spiked bags in the storage closet. He thought his fingerprints would be on them because he had not worn gloves, and described placing tainted bags into circulation at random. The physical evidence he imagined as damning had been found, tested, and retained; nevertheless, the passage of time without a public resolution led him to conclude that the hospital was unwilling or unable to act.

Institutional consequences and meaning

The investigation also changed how insulin was handled on the nursing floor. Under the new procedure, nurses had to sign an insulin adjustment form and record their estimate of how much remained in a vial. Amy Loughren objected: she considered the estimate unreliable and refused to put her electronic signature on it, while her manager would not explain why insulin was suddenly being treated with heightened controls. Her resistance arose from the same unresolved question the bags had raised: what had happened to make an ordinary medication require a new level of accountability?

When police later showed Loughren a Pyxis printout from the night Reverend Florian Gall died, she began to consider that Cullen might have done something terrible. That evidence concerned medication access in a different investigation; it was not a test result from the Saint Barnabas bags. The distinction matters. The bags exposed a concrete pattern of insulin contamination, while schedules, records, and interviews were needed to connect suspected conduct to a person. For Loughren, the investigation also put her friendship with Cullen and her place at the hospital under strain: colleagues knew she was his friend, and she feared that cooperating could cost her job. Eventually, she shared records and assisted investigators.

The bags therefore stand at the junction of clinical observation and institutional proof. Their contents explained why patients deteriorated; the punctures made accidental contamination less plausible; and their preservation gave investigators physical evidence to test against charts and shift schedules. But an object can reveal the mechanism of harm without resolving responsibility. At Saint Barnabas, the bags made the poisoning legible, while the difficulty of proving who had handled them exposed the distance between recognizing danger and stopping it.